We thank the U.S. Department of Health and Human Services (HHS) for awarding $590 million to Moderna to accelerate the development of vaccines against bird flu and other influenza viruses. This vital investment will help protect public health by supporting vaccine development, licensure, and expanded studies to prevent future outbreaks. Bird flu has spread across the U.S., with confirmed human cases and fatalities. The federal government’s proactive funding ensures preparedness against unpredictable virus variants and strengthens public safety. We commend HHS for this crucial step and urge continued focus on advancing public health initiatives. Thank you for prioritizing the well-being of Americans.